This brand name is authorized in Austria, France, Ireland, Netherlands, Poland, United Kingdom
The drug SALVACYL contains one active pharmaceutical ingredient (API):
|
1
Triptorelin
UNII 9081Y98W2V - TRIPTORELIN
|
|
Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| SALVACYL Powder and solvent for prolonged-release suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L02AE04 | Triptorelin | L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 69847994 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 347326 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 77615 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100340690 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
